NEW YORK – The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) recently published a set of guidelines for in vitro diagnostics manufacturers in the event that the UK leaves the European Union without a deal.

British Prime Minister Boris Johnson has reiterated that the UK will exit the EU by the end of the month with or without a deal. If the UK does leave the EU on Oct. 31 without a deal, MHRA will take on the responsibilities for regulating medical devices and IVDs currently overseen by the EU.